TCW GROUP INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
TCW GROUP INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$7,487,525
-2.7%
73,508
-3.6%
0.09%
+10.6%
Q2 2023$7,693,681
+9.7%
76,243
-0.0%
0.08%
-5.6%
Q1 2023$7,015,920
+7.1%
76,260
+5.7%
0.09%
-4.3%
Q4 2022$6,548,260
+19.4%
72,181
+0.0%
0.09%
+17.5%
Q3 2022$5,485,000
-9.9%
72,159
+0.2%
0.08%0.0%
Q2 2022$6,089,000
-4.7%
72,039
-1.1%
0.08%
+31.1%
Q1 2022$6,391,000
+0.3%
72,830
-0.1%
0.06%
+17.3%
Q4 2021$6,374,000
+6.9%
72,868
-0.0%
0.05%
+246.7%
Q3 2021$5,960,000
-10.6%
72,873
-0.2%
0.02%
-74.1%
Q2 2021$6,664,000
-5.8%
73,049
-11.7%
0.06%
-14.7%
Q1 2021$7,071,000
-9.8%
82,719
-0.3%
0.07%0.0%
Q4 2020$7,835,000
-11.6%
82,980
-18.6%
0.07%
-29.9%
Q3 2020$8,862,000
-0.2%
101,902
+0.2%
0.10%
-6.7%
Q2 2020$8,884,000
-1.0%
101,717
-6.5%
0.10%
-16.1%
Q1 2020$8,972,000
-12.9%
108,821
+0.1%
0.12%
+8.8%
Q4 2019$10,297,000
+12.7%
108,745
+3.5%
0.11%
+9.6%
Q3 2019$9,134,000
-4.6%
105,114
+0.2%
0.10%
+2.0%
Q2 2019$9,574,000
-41.9%
104,860
-38.8%
0.10%
-35.4%
Q1 2019$16,474,000
-7.6%
171,353
-17.5%
0.16%
-14.1%
Q4 2018$17,821,000
-0.9%
207,689
-0.5%
0.18%
+25.2%
Q3 2018$17,986,000
+49.4%
208,744
+31.0%
0.15%
+50.0%
Q2 2018$12,037,000
+15.7%
159,356
+23.8%
0.10%
+15.3%
Q1 2018$10,408,000
+7.9%
128,731
+12.0%
0.08%
+9.0%
Q4 2017$9,648,000
+165.5%
114,912
+171.5%
0.08%
+169.0%
Q3 2017$3,634,000
-3.4%
42,326
-6.1%
0.03%
-6.5%
Q2 2017$3,763,000
+117.1%
45,081
+93.2%
0.03%
+121.4%
Q1 2017$1,733,000
+1.9%
23,3360.0%0.01%
+7.7%
Q4 2016$1,700,000
-7.3%
23,336
+0.5%
0.01%
-7.1%
Q3 2016$1,833,000
+6.9%
23,213
+11.7%
0.01%
+7.7%
Q2 2016$1,714,000
+13.9%
20,7760.0%0.01%
+18.2%
Q1 2016$1,505,000
-21.0%
20,776
-6.2%
0.01%
-21.4%
Q4 2015$1,906,000
-9.5%
22,151
-3.4%
0.01%
-6.7%
Q3 2015$2,107,000
-29.2%
22,926
-24.3%
0.02%
-21.1%
Q2 2015$2,978,000
-0.3%
30,2760.0%0.02%
+35.7%
Q1 2015$2,986,000
+46.1%
30,276
+37.2%
0.01%
+55.6%
Q4 2014$2,044,000
-51.5%
22,064
-50.7%
0.01%
-47.1%
Q3 2014$4,214,000
+4.0%
44,7740.0%0.02%0.0%
Q2 2014$4,053,000
+39.0%
44,774
+30.6%
0.02%
+41.7%
Q1 2014$2,915,000
-24.6%
34,294
-28.7%
0.01%
-25.0%
Q4 2013$3,864,000
+24.3%
48,069
+18.6%
0.02%
+14.3%
Q3 2013$3,109,000
-45.7%
40,524
-50.0%
0.01%0.0%
Q2 2013$5,730,00081,0480.01%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders